Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

CRISPR Therapeutics (NasdaqGM:CRSP) witnessed a substantial price movement, increasing 57% over the last quarter. This significant rise aligns with key developments, such as the company's inclusion in ...

A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program ...

Trisomy is a genetic condition characterized by the presence of an extra chromosome. This means that the affected person has ...

The global CRISPR gene editing market size is calculated at USD 4.77 billion in 2025 and is expected to reach around USD ...

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.

KJ Muldoon recently made history by becoming the first patient to receive a personalized CRISPR gene therapy, designed specifically for the genetic mutations causing his rare metabolic disease. | KJ ...

New research has found a novel target with therapeutic potential for metastatic eye melanoma—an aggressive eye cancer—with ...

Scientists have created a near-copy of the long-extinct dire wolf. Using advanced CRISPR gene editing tech, it now looks ...

The Byers Award recognizes outstanding research by faculty members in the middle of their careers. Martin Kampman’s honorary 2025 lecture is titled “A CRISPR approach to neurodegenerative diseases.” ...

Researchers used CRISPR to find a pair of genes that show strong potential as a new therapeutic target for uveal melanoma – a ...

Martin Kampmann, PhD, delivers the 2025 Byers Lecture. Photo by Sonya YruelWhen Martin Kampmann, PhD, set out to explore the ...